other · Healthcare · Biotechnology
ATAI
7.14-0.06 -0.77%Past year
Loading chart…
Loading financials…
Company snapshot
- Ticker
- ATAI
- Exchange
- NGM
- Sector
- Healthcare
- Industry
- Biotechnology
- Market cap
- $2.63B
- Employees
- 99
- Currency
- USD
- Website
- https://www.ataibeckley.com
AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is in Phase 2a and 2b clinical studies for treatment resistant depression (TRD) and alcohol use disorder; RL-007, an orally bioavailable…
Latest coverage
No coverage yet — articles appear here automatically as press releases are published.
Related other stocks
Quotes & data
Follow AtaiBeckley Inc. (ATAI) across major market-data sources.